Laryngeal dysfunction is prominent in asthmatic women treated by inhaled corticosteroids.
Fiche publication
Date publication
décembre 2022
Journal
Clinical and translational allergy
Auteurs
Membres identifiés du Cancéropôle Est :
Pr VELTEN Michel
Tous les auteurs :
Migueres N, Delmas C, Petit Thomas J, Kuntz H, Peri-Fontaa E, Schultz P, Velten M, de Blay F
Lien Pubmed
Résumé
Dysphonia is a frequent comorbidity of asthma and has been suggested to be a local side effect of inhaled corticosteroids due to laryngeal candidiasis. We hypothesized that dysphonia in asthmatics was not due to laryngeal organic lesions but to laryngeal dysfunction during phonation (LDP).
Mots clés
asthma, dysphonia, inhaled corticosteroid, phonation disorders
Référence
Clin Transl Allergy. 2022 12;12(12):e12211